AI and Machine Learning in Site Selection: Separating Real Clinical Trial Results From Marketing Claims by Reed Seward
AI and machine learning in site selection have become popular topics in the clinical research industry. Many pharmaceutical companies now use advanced data systems to improve trial planning. These tools promise better patient recruitment, lower costs, and faster study completion. Some experts see strong value in this technology. Others believe the industry sometimes promotes unrealistic expectations, as Reed Seward defines them.